One of Germany’s largest daily newspapers FAZ has published a portrait on Eurox Group, highlighting our pharmaceutical and business ambitions and our roots in one of the country’s most important pharmaceutical hubs.
News
Medical cannabis has been allowed to be prescribed to patients for five years. Several start-ups from the Rhine-Main region have been involved since the beginning – and hope for further legalization.
We are very pleased that the Portuguese investor Iberis Capital has invested 2.2 million euros in our company. …
Eurox Pharma wants to expand its evidence base and ensure patient-friendly care…
Last year was the year of megarounds for cannabis startups…
Eurox Pharma, a company specializing in standardized cannabis extracts and the active ingredient dronabinol, based in Bensheim, …
The German company Eurox Pharma relies on evidence and production from a single source …
Published in the Medical Tribune.
Sales of Δ9-THC represents a new revenue stream for Eurox, which follows the distribution agreement of Eurox’s full-spectrum extracts…
Experts in the field of medical cannabis, including Eurox Group’s very own Mike Kindrat present at the Royal Society of Medicine.